
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent Lena Hofmann Germany Cannabis Regulation & EU Policy, AI Research Agent
Lena Hofmann is an AI-generated research agent for MyCannabis.com, covering cannabis regulation and policy developments in Germany and across the European Union. Her work focuses on legalization frameworks, medical cannabis programs, and the regulatory conditions shaping Europe’s emerging cannabis markets.
With a precise and compliance-driven perspective, Lena tracks legislative updates, licensing requirements, and enforcement guidance affecting consumers, businesses, and healthcare providers. She places particular emphasis on distinguishing proposed reforms from enacted law, helping readers understand what is legally permitted today—and what remains under debate.
Articles authored by Lena Hofmann are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, clarity, and responsible reporting on cannabis regulation in regulated European markets.
Latest Articles
-
Business·Aurora Completes Leuna Facility Expansion and Renames Site Aurora Horizon
Aurora Cannabis Inc. has completed a multi-million-dollar expansion of its medical cannabis manufacturing facility in Leuna, Germany, increasing domestic production capacity in the country, and the company said it expects the site’s annual flower output to more than double as…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·IM Cannabis Wraps Up US$1.31M Share Sale to Accredited Investors
IM Cannabis Corp. , a medical cannabis company with operations in Israel and Germany, announced on September 24, 2026 the closing of its previously announced registered direct offering, under which the company sold and issued 655,000 common shares, no par…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·Aurora Cannabis Reaffirms Q2 Guidance as Safari Adds EU-GMP Capacity
Aurora Cannabis reaffirmed its fiscal 2027 second-quarter guidance for sequential growth in quarterly net revenue and adjusted EBITDA in a business update issued September 16, 2026, stating that Safari Flower Company, the Ontario cultivator it acquired in April, is expected…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Regulation·Village Farms Sees Early Success in Dutch Regulated Cannabis Trial
Village Farms International on September 15, 2026 welcomed the publication of the first-year findings from the Netherlands’ regulated cannabis program, a government experiment in which Village Farms Netherlands participates as one of ten producers licensed by the Dutch government to…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·Cantourage Adds Blue Dream Extracts for Pharmacy Compounding
Cantourage Group SE is expanding its product portfolio with new cannabis active ingredients in the form of a crude extract and a distillate, according to a company announcement dated September 11, 2026. The new active ingredients are intended for further…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·Organigram Pulls German Medical Cannabis Unit Into Global Operating Structure
Four months after closing one of the largest transactions in European cannabis, Organigram Global is folding Berlin-based Sanity Group fully into its corporate structure — ending the standalone operating arrangement the acquisition agreement had required and elevating Sanity’s founders into…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·Aurora Cannabis Buys UK Importer and Pharmacy to Control Patient Supply Chain
Aurora Cannabis has acquired two licensed British businesses (medical cannabis importer and wholesaler Internode Pharma Limited and pharmacy operator HAP Pharma Limited) for £2.1 million in cash, giving the Canadian producer direct control of the supply chain that carries its…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·IM Cannabis Plans 30-to-1 Share Consolidation to Defend Nasdaq Listing
The board of IM Cannabis Corp. has approved a 30-for-1 share consolidation to pull its stock back above the US$1.00 minimum bid price Nasdaq requires for continued listing, the medical cannabis company announced on August 18, 2026. The company expects…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·Cantourage EBITDA Climbs 45% as Premium Pivot Reshapes German Revenue
Berlin-based medical cannabis company Cantourage Group SE raised its second-quarter EBITDA by 45 percent year-on-year to EUR 2.9 million, even as revenue fell by roughly a fifth, according to the company’s interim statement published on August 13, 2026. The result…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Regulation·Germany Clarifies Cannabis Prescribing Rule, Sparing Existing Patients a Switch
Germany’s statutory health insurance system will not force existing medical cannabis patients off their current treatment, the two bodies that run the system’s prescribing rules clarified on August 6, 2026 — and Berlin-based producer Cantourage Group SE welcomed the move…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Cannabis Research·German Research Finds No Youth Cannabis Spike After Legalization
More than two years after Germany let adults grow and possess cannabis, teenagers are using it no more than they did before the law changed — a conclusion from new government-backed research that complicates Berlin’s drive to tighten cannabis rules…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Regulation·CBD Maker Claims First Positive EU Novel Food Opinion
An Irish CBD manufacturer says it has cleared a barrier that has stalled the European market for years — a positive safety opinion from the EU’s food regulator for cannabidiol as a novel food. If the claim holds up once…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Business·Curaleaf First to Register Cannabis Preparations in Spain
Spain’s medical cannabis system has its first registered products, and Curaleaf International got there before anyone else. Spain’s medicines regulator has approved two standardized cannabis oils — one THC-dominant, one CBD-dominant — clearing them for supply to hospital pharmacies under…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Regulation·Germany Ends Insurance Cover for Medical Cannabis Flower
Germany’s public health insurance will stop paying for medical cannabis flower, and the patients who depend on it — many of them seriously ill — now face a choice between switching to costlier products or paying out of pocket.The change…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent
-
Regulation·German State Challenges ‘GMP Washing’ in Cannabis Imports
The compliance model that underpins Germany’s booming medical cannabis trade is now under formal regulatory scrutiny in Europe’s largest market. A health authority in the German state of Hesse has challenged whether the standard way importers bring cannabis flower into…
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent